Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Alnylam Pharmaceuticals
ALNY
$38.3B
| $1.03M | ﹤0.01% |
+8,100
| New | +$1.02M |
|
2652
Seagate
STX
$173B
| $1.03M | ﹤0.01% |
+24,600
| New | +$940K |
|
|
AVID
2653
DELISTED
Avid Technology Inc
AVID
| $1.02M | ﹤0.01% |
+189,504
| New | +$1.02M |
|
2654
Vanguard Industrials ETF
VIS
$7.94B
| $1.01M | ﹤0.01% |
+7,100
| New | +$974K |
|
|
LITB
2655
LightInTheBox
LITB
$50.6M
| $1M | ﹤0.01% |
72,600
+17,833
| +33% | +$217K |
|
|
CBD
2656
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $1M | ﹤0.01% |
+42,500
| New | +$984K |
|
|
RBCN
2657
DELISTED
Rubicon Technology, Inc.
RBCN
| $999K | ﹤0.01% |
125,140
+6,300
| +5% | +$51.4K |
|
2658
Aqua Metals
AQMS
$9.78M
| $994K | ﹤0.01% |
+2,333
| New | +$1.76M |
|
2659
DLH Holdings
DLHC
$78.3M
| $994K | ﹤0.01% |
161,290
+13,200
| +9% | +$81.5K |
|
2660
NN Inc
NNBR
$237M
| $994K | ﹤0.01% |
36,000
-40,686
| -53% | -$1.16M |
|
|
AGRX
2661
DELISTED
Agile Therapeutics
AGRX
| $985K | ﹤0.01% |
183
+139
| +316% | +$1.29M |
|
2662
Huron Consulting
HURN
$2.76B
| $981K | ﹤0.01% |
24,258
-46,600
| -66% | -$1.79M |
|
|
NRCIB
2663
DELISTED
National Research Corp Class B
NRCIB
| $981K | ﹤0.01% |
17,500
+9,157
| +110% | +$490K |
|
|
QBAK
2664
DELISTED
Qualstar Corp
QBAK
| $981K | ﹤0.01% |
116,802
+19,900
| +21% | +$149K |
|
|
ATYR
2665
aTyr Pharma
ATYR
$47.4M
| $978K | ﹤0.01% |
19,957
+11,750
| +143% | +$722K |
|
2666
FreightCar America
RAIL
$263M
| $974K | ﹤0.01% |
57,000
+15,201
| +36% | +$262K |
|
|
LOAN
2667
Manhattan Bridge Capital
LOAN
$48M
| $970K | ﹤0.01% |
163,200
+36,400
| +29% | +$215K |
|
2668
CONMED
CNMD
$1.3B
| $968K | ﹤0.01% |
19,000
+7,700
| +68% | +$401K |
|
|
FRGI
2669
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $968K | ﹤0.01% |
50,966
+22,500
| +79% | +$405K |
|
|
STAB
2670
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $966K | ﹤0.01% |
241,016
+24,000
| +11% | +$73K |
|
2671
Invesco Financial Preferred ETF
PGF
$674M
| $964K | ﹤0.01% |
+51,100
| New | +$967K |
|
|
VYNT
2672
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $962K | ﹤0.01% |
3,465
-331
| -9% | -$126K |
|
2673
Alphatec Holdings
ATEC
$1.48B
| $955K | ﹤0.01% |
359,087
+33,300
| +10% | +$107K |
|
|
EBTC
2674
DELISTED
Enterprise Bancorp
EBTC
| $955K | ﹤0.01% |
28,048
+2,948
| +12% | +$106K |
|
2675
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.07B
| $954K | ﹤0.01% |
+31,121
| New | +$956K |
|
Similar funds
Renaissance Technologies's Q4 2017 Portfolio in Review
As of Q4 2017, Renaissance Technologies held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Renaissance Technologies's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Renaissance Technologies added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Renaissance Technologies's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Renaissance Technologies fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Renaissance Technologies's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Renaissance Technologies opened 521 new positions and closed 386 in Q4 2017.
- Renaissance Technologies's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.